Akari Therapeutics
$1.529876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.15 (-8.98%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell AKTX and other stocks, options, ETFs, and crypto commission-free!
About AKTX
Akari Therapeutics Plc ADR, also called Akari Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Read More The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
Employees
14
Headquarters
London, London & South East
Founded
2004
Market Cap
32.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
96.75K
High Today
$1.59
Low Today
$1.51
Open Price
$1.51
Volume
107.39K
52 Week High
$5.04
52 Week Low
$0.87
Collections
AKTX Earnings
-$0.47
-$0.31
-$0.16
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Apr 21, After Hours